Occurrence and significance of epithelial-mesenchymal transition in breast cancer

被引:36
|
作者
Roxanis, Ioannis [1 ]
机构
[1] Oxford Univ Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England
关键词
RECEPTOR TYROSINE KINASES; E-CADHERIN EXPRESSION; ACTIVATED AKT KINASE; GROWTH-FACTOR-BETA; TGF-BETA; TUMOR PROGRESSION; BASAL-LIKE; DUCTAL CARCINOMA; COLORECTAL CANCERS; SIGNALING PATHWAYS;
D O I
10.1136/jclinpath-2012-201348
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
By contrast with developmental epithelial-mesenchymal transition (EMT), where epithelial characteristics undergo transformation to a mesenchymal-like phenotype in a coordinated fashion, oncogenic EMT occurs in the context of unpredictable genetic changes present in the tumour cells, as well as an abnormal tumour microenvironment. Therefore, a partial form of EMT has been proposed as variably participating in the establishment of invasive phenotype in different types of breast carcinoma, in keeping with their morphological and phenotypical diversity. A complex network of signalling pathways and transcription factors appears responding to various growth factors and cytokines released by stromal and neoplastic elements, endowing the system with abundant regulatory opportunities. The process of EMT is largely elusive in histopathological preparations, prompting doubts regarding its significance in tumour progression. This might be related to the presumed focal occurrence of EMT in the majority of tumours. Detailed topological studies might facilitate understanding of the orchestration of events taking place in vivo. Even more importantly, clinical correlations can be endeavoured and, in parallel with advancement in molecular pathology, a contribution to taxonomy refinement can be envisaged.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 50 条
  • [1] Epithelial-mesenchymal transition in development and cancer
    Micalizzi, Douglas S.
    Ford, Heide L.
    FUTURE ONCOLOGY, 2009, 5 (08) : 1129 - 1143
  • [2] Epithelial-Mesenchymal Transition and Breast Cancer
    Wu, Yanyuan
    Sarkissyan, Marianna
    Vadgama, Jaydutt V.
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (02)
  • [3] Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer
    Lundgren, K.
    Nordenskjold, B.
    Landberg, G.
    BRITISH JOURNAL OF CANCER, 2009, 101 (10) : 1769 - 1781
  • [4] Epithelial-mesenchymal transition in ovarian cancer
    Vergara, Daniele
    Merlot, Benjamin
    Lucot, Jean-Philippe
    Collinet, Pierre
    Vinatier, Denis
    Fournier, Isabelle
    Salzet, Michel
    CANCER LETTERS, 2010, 291 (01) : 59 - 66
  • [5] ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer
    Guttilla, Irene K.
    Adams, Brian D.
    White, Bruce A.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2012, 23 (02) : 73 - 82
  • [6] Epithelial-mesenchymal transition and drug resistance in breast cancer
    Huang, Jing
    Li, Hongzhong
    Ren, Guosheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 840 - 848
  • [7] Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
    Figiel, Sandy
    Vasseur, Caroline
    Bruyere, Franck
    Rozet, Francois
    Maheo, Karine
    Fromont, Gaelle
    HUMAN PATHOLOGY, 2017, 61 : 26 - 32
  • [8] Epithelial-mesenchymal transition in cancer development and its clinical significance
    Iwatsuki, Masaaki
    Mimori, Koshi
    Yokobori, Takehiko
    Ishi, Hideshi
    Beppu, Toru
    Nakamori, Shoji
    Baba, Hideo
    Mori, Masaki
    CANCER SCIENCE, 2010, 101 (02): : 293 - 299
  • [9] Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells
    Kim, Hyun A.
    Lee, Joomin
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [10] Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer
    Khadri, Fatima-Zohra
    Issac, Marianne Samir Makboul
    Gaboury, Louis Arthur
    CANCERS, 2021, 13 (20)